EPO revokes patent for transgenic mice and rats

09-07-2015

EPO revokes patent for transgenic mice and rats

CreativeNature R.Zwerver / Shutterstock.com

The European Patent Office (EPO) has invalidated a patent covering genetically modified mice and rats.


EPO; patents; European Patent Convention; Altor Bioscience; Regeneron Pharmaceuticals; GeneWatch UK; biotechnology

LSIPR